Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
about
Advances in Lipidomics for Cancer Biomarkers DiscoveryFenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions.Phospholipids as cancer biomarkers: Mass spectrometry-based analysis.Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.Promising pharmacological directions in the world of lysophosphatidic Acid signaling.Focal Adhesion Kinase Expression in Ameloblastoma: A Preliminary Observational StudyAMPK/p53 Axis Is Essential for α-Lipoic Acid-Regulated Metastasis in Human and Mouse Colon Cancer Cells.Down-regulation of malignant potential by alpha linolenic acid in human and mouse colon cancer cells.Inhibitory role of polyunsaturated fatty acids on lysophosphatidic acid-induced cancer cell migration and adhesion.Systems Chemo-Biology and Transcriptomic Meta-Analysis Reveal the Molecular Roles of Bioactive Lipids in Cardiomyocyte Differentiation.Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study.Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
P2860
Q28079507-E2D1D9E3-93AC-4158-A8CE-69848FE4726CQ35562797-76E85428-2496-43F8-A4A4-4F1D78A59F78Q36045221-5065CD1C-DD20-41C1-9C37-06B830872B09Q36662210-05B6AA88-8BBF-4B0D-94A4-349337933162Q38320338-42B24A7C-F390-47D4-AA05-3F82497C6840Q38372651-3C33B0CB-3079-45A9-91D5-9191777C3C80Q38423028-F20A2F54-1340-4C31-9899-F3F454174F12Q38432718-9BF41941-8C0A-40FE-BACB-D53AB5900736Q38986708-498C6804-BBD7-4060-90FB-1CF2B4279308Q41265082-0F4429CE-3EE3-4D98-8C38-0AB899228199Q47108985-9D87A8EC-DAD3-47D4-8AF8-2A188B89F687Q50074055-998899BE-04AB-47BA-934C-1AEDFE8C4C9AQ52654840-1B8E0750-68DA-417C-AFD1-248BEE6BC343
P2860
Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lysophosphatidic acid stimulat ...... 3, in human pancreatic cancer.
@en
Lysophosphatidic acid stimulat ...... 3, in human pancreatic cancer.
@nl
type
label
Lysophosphatidic acid stimulat ...... 3, in human pancreatic cancer.
@en
Lysophosphatidic acid stimulat ...... 3, in human pancreatic cancer.
@nl
prefLabel
Lysophosphatidic acid stimulat ...... 3, in human pancreatic cancer.
@en
Lysophosphatidic acid stimulat ...... 3, in human pancreatic cancer.
@nl
P2093
P2860
P1476
Lysophosphatidic acid stimulat ...... 3, in human pancreatic cancer.
@en
P2093
Ganggang Mu
Honggang Yu
Lingli Zhang
P2860
P2888
P304
P356
10.1007/S10620-013-2878-4
P577
2013-09-24T00:00:00Z